UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization

Pharmaceuticals (Basel, Switzerland), 2017-08, Vol.10 (3), p.72

2017

Volltextzugriff (PDF)

Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates

Molecules (Basel, Switzerland), 2018-06, Vol.23 (6), p.1465

2018

Volltextzugriff (PDF)

Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma

BMC cancer, 2018-09, Vol.18 (1), p.922-922, Article 922

2018

Volltextzugriff (PDF)

A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides

EJNMMI research, 2023-04, Vol.13 (1), p.32-32, Article 32

2023

Volltextzugriff (PDF)

18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease—A Proof-of-Concept Study

Frontiers in immunology, 2019-11, Vol.10

2019

Volltextzugriff (PDF)

Simultaneous Visualization of 161Tb- and 177Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging

Pharmaceutics, 2021-04, Vol.13 (4), p.536

2021

Volltextzugriff (PDF)

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects

Cancer medicine (Malden, MA), 2022-10, Vol.11 (20), p.3820-3836

2022

Volltextzugriff (PDF)

The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor

The international journal of biochemistry & cell biology, 2009-07, Vol.41 (7), p.1572-1580

2009

Volltextzugriff (PDF)

Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis

Clinical cancer research, 2007-01, Vol.13 (2), p.603-611

2007

Volltextzugriff (PDF)

Combined Application of Albumin-Binding [ 177 Lu]Lu-PSMA-ALB-56 and Fast-Cleared PSMA Inhibitors: Optimization of the Pharmacokinetics

Molecular pharmaceutics, 2020-06, Vol.17 (6), p.2044-2053

2020

Volltextzugriff (PDF)

Promising potential of [[.sup.177]Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy--a preclinical study using a syngeneic breast cancer model

European journal of nuclear medicine and molecular imaging, 2021-04, Vol.48 (4), p.984

2021

Volltextzugriff (PDF)

Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model

European journal of nuclear medicine and molecular imaging, 2021-04, Vol.48 (4), p.984-994

2021

Volltextzugriff (PDF)

Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy

Journal of Nuclear Medicine, 2021-10, Vol.62 (10), p.1475-1481

2021

Volltextzugriff (PDF)

The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy

Nuclear medicine and biology, 2011-08, Vol.38 (6), p.917-924

2011

Volltextzugriff (PDF)

Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model

European journal of nuclear medicine and molecular imaging, 2014-10, Vol.41 (10), p.1907-1915

2014

Volltextzugriff (PDF)

Evaluation of the first (44)Sc-labeled Affibody molecule for imaging of HER2-expressing tumors

Nuclear medicine and biology, 2017-02, Vol.45, p.15

2017

Volltextzugriff (PDF)

Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors

Nuclear medicine and biology, 2017-02, Vol.45, p.15-21

2017

Volltextzugriff (PDF)

Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model

EJNMMI research, 2014-10, Vol.4 (1), p.54-54, Article 54

2014

Volltextzugriff (PDF)

L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancer

International journal of cancer, 2012-06, Vol.130 (11), p.2715-2721

2012

Volltextzugriff (PDF)

In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs

Molecular pharmaceutics, 2018-11, Vol.15 (11), p.4995-5004

2018

Volltextzugriff (PDF)

Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice

Nuclear medicine and biology, 2014-05, Vol.41, p.e58-e65

2014

Volltextzugriff (PDF)

Simultaneous Visualization of 161 Tb- and 177 Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging

Pharmaceutics, 2021-04, Vol.13 (4)

2021

Volltextzugriff (PDF)

L1-CAM-targeted antibody therapy and 177Lu-radioimmunotherapy of disseminated ovarian cancer

International journal of cancer, 2012-06, Vol.130 (11), p.2715-2721

2012

Volltextzugriff (PDF)

Evaluation of the first ^sup 44^Sc-labeled Affibody molecule for imaging of HER2-expressing tumors

Nuclear medicine and biology, 2017-02, Vol.45, p.15

2017

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Humans
(27)
Female
(20)
Animals
(13)
Male
(10)
Mice
(10)
Biological And Medical Sciences
(9)
Middle Aged
(9)
Oncology
(9)
Aged
(8)
Cell Line, Tumor
(8)
Diabetes
(8)
Medical Sciences
(8)
Tumors
(8)
Weight Loss
(8)
Diabetes Mellitus, Type 2 - Complications
(7)
Obesity - Complications
(7)
Radiology
(7)
Radiology, Nuclear Medicine & Medical Imaging
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization

Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates

Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma

A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides

18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease—A Proof-of-Concept Study

Simultaneous Visualization of 161Tb- and 177Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects

The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor

Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis

Combined Application of Albumin-Binding [ 177 Lu]Lu-PSMA-ALB-56 and Fast-Cleared PSMA Inhibitors: Optimization of the Pharmacokinetics

Promising potential of [[.sup.177]Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy--a preclinical study using a syngeneic breast cancer model

Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model

Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy

The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy

Transplantation and Tracking of Human-Induced Pluripotent Stem Cells in a Pig Model of Myocardial Infarction Assessment of Cell Survival, Engraftment, and Distribution by Hybrid Single Photon Emission Computed Tomography/Computed Tomography of Sodium Iodide Symporter Transgene Expression

Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model

Evaluation of the first (44)Sc-labeled Affibody molecule for imaging of HER2-expressing tumors

Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors

Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model

L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancer

In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs

Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice

Simultaneous Visualization of 161 Tb- and 177 Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging

L1-CAM-targeted antibody therapy and 177Lu-radioimmunotherapy of disseminated ovarian cancer

Evaluation of the first ^sup 44^Sc-labeled Affibody molecule for imaging of HER2-expressing tumors

Suchergebnisse filtern